An additional TP53 mutation alters the effects of cellular senescence in RasG12V cell from tumour-suppressive to SASP-mediated tumorigenic, and SASP secretion from the Ras-TP53 double mutant cell converts its neighbouring normal cells into senescent cells, thereby priming neoplastic development. The gene discussed is TP53; the disease is neoplasm.